|
|
||||||||
Original Articles |
Type I and type III are the most abundant collagens in the lung. The aim of our study was to compare type I and III procollagen peptides in sera of sarcoid patients. Sixty eight patients with sarcoidosis were studied (19 with newly recognized disease, 7 with relapsing disease, 15 with chronic disease, and 27 in stable remission). Thirty healthy volunteers served as controls. The levels of procollagen I and III peptides were determined by radioimmunoassay. Angiotensin-converting enzyme (ACE) level was evaluated by means of a colorimetric assay. In patients with newly recognized sarcoidosis, both serum procollagen I and III peptide levels were increased with respect to controls (p=0.0014 and p<0.00001, respectively). There was a poor correlation between levels of procollagen I and III (r=0.26), whereas there was a closer correlation between procollagen III and ACE (r=0.69). Procollagen I peptide level did not identify patients in roentgenological stage III. In conclusion, in patients with newly recognized sarcoidosis there is a significant increase in the serum level of procollagen I peptide. However, procollagen I peptide is not a marker of sarcoid patients with fibrosis, ie. stage III disease. Its clinical usefulness seems to be weaker than that of procollagen III peptide.
This article has been cited by other articles:
![]() |
T. Rampino, G. Cancarini, M. Gregorini, P. Guallini, M. Maggio, A. Ranghino, G. Soccio, and A. Dal Canton Hepatocyte Growth Factor/Scatter Factor Released during Peritonitis Is Active on Mesothelial Cells Am. J. Pathol., October 1, 2001; 159(4): 1275 - 1285. [Abstract] [Full Text] |
||||
![]() |
L. LAMMI, L. RYHÄNEN, E. LAKARI, J. RISTELI, P. PÄÄKKÖ, K. KAHLOS, S. LÄHDE, and V. KINNULA Type III and Type I Procollagen Markers in Fibrosing Alveolitis Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 818 - 823. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |